Corbus Pharmaceuticals Holdings, Inc.
Total Trades
32
Buys
11
Sells
14
Largest Trade
N/A
Insiders
8
Institutional Funds
72
Inst. Value
$1M+
Activist Filings
31
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Smethurst Dominic | Chief Medical Offi… | SELL | $50K–$100K | 6K | $8.30 | Mar 4, 2026 |
| Hodgson Ian | COO | SELL | $1K–$15K | 847 | $7.38 | Feb 18, 2026 |
| Moran Sean F. | CFO | SELL | $15K–$50K | 5K | $7.78 | Feb 18, 2026 |
| Cohen Yuval | CEO | SELL | $100K–$500K | 14K | $7.78 | Feb 18, 2026 |
| Smethurst Dominic | Chief Medical Offi… | SELL | $15K–$50K | 3K | $8.09 | Feb 4, 2026 |
| Hodgson Ian | COO | SELL | $15K–$50K | 2K | $8.09 | Feb 4, 2026 |
| Cormorant Asset Management, LP | 10% Owner | SELL | $100K–$500K | 30K | $11.46 | Dec 15, 2025 |
| Cohen Yuval | CEO | SELL | $100K–$500K | 28K | $17.05 | Oct 27, 2025 |
| Cohen Yuval | CEO | EXERCISE | $100K–$500K | 28K | $4.26 | Oct 27, 2025 |
| Moran Sean F. | CFO | SELL | $100K–$500K | 13K | $17.02 | Oct 27, 2025 |
| Moran Sean F. | CFO | EXERCISE | $50K–$100K | 13K | $4.26 | Oct 27, 2025 |
| Altmeyer Anne | Director | EXERCISE | $1K–$15K | 1K | $4.80 | Oct 21, 2025 |
| Altmeyer Anne | Director | SELL | $15K–$50K | 1K | $20.50 | Oct 21, 2025 |
| Jenkins John Kenneth | Director | GRANT | N/A | 5K | — | Jun 2, 2025 |
| Jenkins John Kenneth | Director | SELL | $15K–$50K | 3K | $7.35 | Jun 2, 2025 |
| Altmeyer Anne | Director | GRANT | N/A | 5K | — | Jun 2, 2025 |
| Altmeyer Anne | Director | SELL | $1K–$15K | 1K | $7.25 | Jun 2, 2025 |
| Cormorant Asset Management, LP | 10% Owner | BUY | $1M+ | 350K | $20.01 | Sep 24, 2024 |
| Moran Sean F. | CFO | SELL | $500K+ | 18K | $47.88 | Jun 18, 2024 |
| Moran Sean F. | CFO | EXERCISE | $100K–$500K | 18K | $12.96 | Jun 18, 2024 |
| Cohen Yuval | CEO | SELL | $1M+ | 63K | $46.57 | Jun 18, 2024 |
| Cohen Yuval | CEO | EXERCISE | $500K+ | 56K | $17.14 | Jun 18, 2024 |
| Cormorant Asset Management, LP | 10% Owner | BUY | $1M+ | 750K | $19.00 | Feb 6, 2024 |
| Cormorant Asset Management, LP | 10% Owner | BUY | $1M+ | 283K | $32.24 | Jan 30, 2024 |
| Millian Craig Stuart | COO | BUY | $1K–$15K | 5K | $0.25 | Aug 12, 2022 |
| Cohen Yuval | CEO | BUY | $1K–$15K | 4K | $0.26 | Aug 11, 2022 |
| Moran Sean F. | CFO | BUY | $1K–$15K | 20K | $0.26 | Aug 10, 2022 |
| Moran Sean F. | CFO | BUY | $1K–$15K | 12K | $0.30 | May 16, 2022 |
| Cohen Yuval | CEO | BUY | $1K–$15K | 11K | $0.25 | May 16, 2022 |
| Millian Craig Stuart | COO | BUY | $1K–$15K | 10K | $0.37 | Mar 11, 2022 |
| Moran Sean F. | CFO | BUY | $1K–$15K | 15K | $0.37 | Mar 10, 2022 |
| Cohen Yuval | CEO | BUY | $1K–$15K | 9K | $0.37 | Mar 9, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 72 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Cormorant Asset Management, LP | 2.3M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 1.6M | $1M+ | SH |
| Aberdeen Group plc | 1.3M | $1M+ | SH |
| Octagon Capital Advisors LP | 955K | $1M+ | SH |
| VANGUARD GROUP INC | 758K | $1M+ | SH |
| Prosight Management, LP | 684K | $1M+ | SH |
| Stonepine Capital Management, LLC | 390K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 354K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 287K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 287K | $1M+ | SH |
| COMERICA BANK | 200K | $1M+ | SH |
| Assenagon Asset Management S.A. | 188K | $1M+ | SH |
| Exome Asset Management LLC | 140K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 138K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 133K | $1M+ | SH |
| Atle Fund Management AB | 107K | $500K+ | SH |
| Point72 Asset Management, L.P. | 75K | $500K+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 71K | $500K+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 60K | $100K–$500K | SH |
| Seven Fleet Capital Management LP | 57K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 10, 2026
5.4%
955K shares
SC 13G · Jan 16, 2026
7.5%
1.3M shares
Cormorant Asset Management, LP
SC 13G/A · Dec 15, 2025
13.4%
2.3M shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2025
12.8%
2.4M shares
SC 13G · Nov 12, 2025
4.7%
873K shares
SC 13G/A · Jul 29, 2025
4.9%
599K shares
SC 13G/A · Jul 16, 2025
2.9%
352K shares
SC 13G/A · Feb 14, 2025
3.7%
454K shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
0.0%
0 shares
SC 13G · Nov 14, 2024
2.7%
323K shares
K2 HealthVentures Equity Trust LLC
SC 13G/A · Nov 14, 2024
0.0%
3K shares
SC 13G/A · Nov 14, 2024
5.0%
600K shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2024
19.5%
2.4M shares
SC 13G/A · Nov 12, 2024
5.4%
646K shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
4.4%
529K shares
SC 13G · Nov 8, 2024
6.7%
803K shares
SC 13G/A · Nov 4, 2024
5.4%
646K shares
SC 13G · Oct 22, 2024
6.7%
803K shares
SC 13G/A · Oct 15, 2024
1.0%
123K shares
SC 13G · Oct 11, 2024
9.3%
1.1M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Mar 18, 2024
19.3%
2.0M shares
SC 13G · Feb 28, 2024
5.3%
544K shares
K2 HealthVentures Equity Trust LLC
SC 13G/A · Feb 14, 2024
7.5%
342K shares
K2 HealthVentures Equity Trust LLC
SC 13G · Feb 14, 2024
7.8%
10.5M shares
Corbus Pharmaceuticals Holdings, Inc. (Subject)
SC 13G · Feb 14, 2024
0.0%
0 shares
SC 13G · Feb 12, 2024
7.7%
796K shares
SC 13G · Feb 12, 2024
4.1%
430K shares
Point72 Asset Management, L.P.
SC 13G · Jan 29, 2024
8.8%
389K shares
SC 13G · Jan 26, 2024
9.6%
426K shares
SC 13G/A · Aug 24, 2022
5.0%
6.2M shares
SC 13G/A · Feb 14, 2022
8.8%
11.0M shares